Interpreting SARS-CoV-2 seroprevalence, deaths, and fatality rate -- making a case for standardized reporting to improve communication

DOI10.1016/J.MBS.2021.108545MaRDI QIDQ2240249zbMATH OpenOpenAlexWikidataFDO

Authors Joseph Cavataio, Santiago Schnell

Publication date 8 November 2021

Published in Mathematical Biosciences (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.mbs.2021.108545

zbMATH Keywords

communicationepidemiologymetrologyfatality ratesrigor and reproducibilitystandard-based guidelines

Mathematics Subject Classification ID

Medical epidemiology (92C60) Epidemiology (92D30) Research exposition (monographs, survey articles) pertaining to biology (92-02)

Recommendations

• COVID-19: optimal design of serosurveys for disease burden estimation
• Estimation of Covid-19 prevalence from serology tests: a partial identification approach
• Estimating the cumulative rate of SARS-CoV-2 infection
• Analysis of serological surveys of antibodies to SARS-CoV-2 in the United States to estimate parameters needed for transmission modeling and to evaluate and improve the accuracy of predictions
• Estimating the SARS-CoV-2 infection fatality rate by data combination: the case of Germany’s first wave
• Estimation of SARS‐CoV‐2 antibody prevalence through serological uncertainty and daily incidence
• Estimating absolute and relative case fatality ratios from infectious disease surveillance data
• Estimating the COVID-19 infection rate: anatomy of an inference problem
• Trends in COVID-19 prevalence and mortality: a year in review

Cites work

• A data-driven network model for the emerging COVID-19 epidemics in Wuhan, Toronto and Italy
• Modeling behavioral change and COVID-19 containment in Mexico: a trade-off between lockdown and compliance
• Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability
• On the benefits of flattening the curve: a perspective

Cited in

(2)

• Comparing the dynamics of COVID-19 infection and mortality in the United States, India, and Brazil
• Trends in COVID-19 prevalence and mortality: a year in review

This page was built for publication: Interpreting SARS-CoV-2 seroprevalence, deaths, and fatality rate -- making a case for standardized reporting to improve communication

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2240249)